Thompson Siegel & Walmsley LLC Sells 31 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

VaselineSeptember 17, 2024

0 5 minutes read

Thompson Siegel & Walmsley LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.3% during the second quarter, according to its most recent filing with the SEC. The fund owned 1,336 shares of the medical conglomerate’s stock after selling 31 shares during the quarter. Thompson Siegel & Walmsley LLC’s holdings in UnitedHealth Group were worth $680,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Macroview Investment Management LLC grew its position in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the health care conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. True Wealth Design LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $31,000. Delos Wealth Advisors LLC boosted its stake in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the medical conglomerate’s stock worth $30,000 after acquiring an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at $31,000. Finally, Signature Resources Capital Management LLC grew its position in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after which bought another 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s shares.

UnitedHealth Group trading fell 0.9%

NYSE:UNH opened at $589.16 on Tuesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The company’s 50-day simple moving average is $571.08 and its 200-day simple moving average is $518.38. The firm has a market cap of $542.25 billion, a P/E ratio of 36.01, a PEG ratio of 1.64 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88, and a quick ratio of 0.88.

Want more great investment ideas?

UnitedHealth Group (NYSE:UNH – Get Your Free Report ) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. In the same quarter last year, the company earned $6.14 EPS. The company’s revenue for the quarter was up 6.4% year over year. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a dividend of $8.40 on an annualized basis and a dividend yield of 1.43%. The ex-dividend date of this dividend is Monday, September 16. UnitedHealth Group’s payout ratio is currently 51.34%.

Analysts on Wall Street are forecasting an increase

UNH has been the subject of several analyst reports. HSBC lifted their price objective on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Monday. Barclays upped their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and increased their target price for the company from $481.00 to $647.00 in a report from Wednesday, July 17. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Moderate Buy” and a consensus price target of $614.17, according to MarketBeat .

Get the latest analysis on UnitedHealth Group

Insider buying and selling

In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is accessible via this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available on the SEC’s website. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of shares are currently held by corporate insiders.

About UnitedHealth Group

(Free report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.